Therapy-related CD7+ acute myeloid leukemia with trisomy 8 following acute monocytic leukemia

Anticancer Drugs. 2001 Sep;12(8):681-2. doi: 10.1097/00001813-200109000-00006.

Abstract

We report a patient who developed CD7+ therapy-related acute myeloid leukemia (t-AML) with trisomy 8 after chemotherapy for AML.

Publication types

  • Case Reports

MeSH terms

  • Antigens, CD7 / analysis
  • Biomarkers, Tumor / analysis
  • Chromosomes, Human, Pair 8 / genetics
  • Cytarabine / adverse effects*
  • Cytarabine / analogs & derivatives*
  • Cytarabine / therapeutic use
  • Daunorubicin / therapeutic use
  • Diagnosis, Differential
  • Female
  • Humans
  • Leukemia, Monocytic, Acute / diagnosis
  • Leukemia, Monocytic, Acute / drug therapy
  • Leukemia, Myeloid / chemically induced*
  • Leukemia, Myeloid / diagnosis
  • Leukemia, Myeloid / genetics*
  • Mercaptopurine / therapeutic use
  • Middle Aged
  • Neoplasms, Second Primary / chemically induced*
  • Neoplasms, Second Primary / diagnosis
  • Neoplasms, Second Primary / genetics*
  • Prednisolone / therapeutic use
  • Trisomy / genetics

Substances

  • Antigens, CD7
  • Biomarkers, Tumor
  • Cytarabine
  • Prednisolone
  • enocitabine
  • Mercaptopurine
  • Daunorubicin